David Dunn creator_ch4eolp74zakxh4y6wd5aqs4kq

Given name David
Surname Dunn

Releases

This creator has contributed to:

2018-09-17 Superiority and non-inferiority: two sides of the same coin?
published | article-journal
doi:10.1186/s13063-018-2885-z
2020-09-18 Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial
published | stub | v1 | CC-BY
doi:10.6084/m9.figshare.c.5125536.v1
2020-09-18 Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial
published | stub | CC-BY
doi:10.6084/m9.figshare.c.5125536
2019-07-12 The Connection between the Averted Infections Ratio and the Rate Ratio in Active-control Trials of Pre-exposure Prophylaxis Agents
published | article-journal
doi:10.1515/scid-2019-0006
2020-09-17 Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial
published | article-journal
doi:10.1186/s13063-020-04718-z
2020-09-18 Additional file 1 of Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial
published | component | CC-BY
doi:10.6084/m9.figshare.12972225
2021 Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT
published | article-journal
doi:10.3310/hta25600
2020-09-18 Additional file 1 of Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial
published | component | v1 | CC-BY
doi:10.6084/m9.figshare.12972225.v1
2021 Using the adherence‚Äźefficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background hiv incidence: a secondary analysis of a randomized, controlled trial
published | article-journal | CC-BY
doi:10.1002/jia2.25744
2021-01-01 Confidence limits for the averted infections ratio estimated via the counterfactual placebo incidence rate
published | article-journal | CC-BY
doi:10.1515/scid-2021-0002
2023-03-31 Electronic health records to capture primary outcome measures: two case studies in HIV prevention research
published | article-journal
doi:10.1186/s13063-023-07264-6
2022-09-22 Dose of approved COVID-19 vaccines is based on weak evidence: a review of early-phase, dose-finding trials
unknown status | post
doi:10.1101/2022.09.20.22276701